+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Central Nervous System Drugs Market Research Reports

From
From
P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021 - Product Thumbnail Image

P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021

  • Report
  • November 2021
  • 70 Pages
  • Global
From
Spinocerebellar Ataxia (SCA) - Pipeline Review, H2 2020 - Product Thumbnail Image

Spinocerebellar Ataxia (SCA) - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 114 Pages
  • Global
From
Transthyretin - Pipeline Review, H2 2020 - Product Thumbnail Image

Transthyretin - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 116 Pages
  • Global
From
Beta Nerve Growth Factor - Pipeline Review, H2 2020 - Product Thumbnail Image

Beta Nerve Growth Factor - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 61 Pages
  • Global
From
Intracranial Aneurysm Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Intracranial Aneurysm Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
REM sleep Behavior Disorder Market 2024-2028 - Product Thumbnail Image

REM sleep Behavior Disorder Market 2024-2028

  • Report
  • October 2024
  • 198 Pages
  • Global
From
Migraine Drugs Market in Latin America 2024-2028 - Product Thumbnail Image

Migraine Drugs Market in Latin America 2024-2028

  • Report
  • September 2024
  • 163 Pages
  • Latin America
From
Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2024-2028 - Product Thumbnail Image

Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2024-2028

  • Report
  • September 2024
  • 167 Pages
  • Global
From
Vertigo Drugs Market 2024-2028 - Product Thumbnail Image

Vertigo Drugs Market 2024-2028

  • Report
  • September 2024
  • 157 Pages
  • Global
From
Narcolepsy Drugs Market 2024-2028 - Product Thumbnail Image

Narcolepsy Drugs Market 2024-2028

  • Report
  • July 2024
  • 133 Pages
  • Global
From
Chronic Fatigue Syndrome Therapeutics Market 2024-2028 - Product Thumbnail Image

Chronic Fatigue Syndrome Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 145 Pages
  • Global
From
Neurologic Disorders Therapeutics Market 2024-2028 - Product Thumbnail Image

Neurologic Disorders Therapeutics Market 2024-2028

  • Report
  • July 2024
  • 150 Pages
  • Global
From
Wilson's Disease (WD) Drugs Market 2024-2028 - Product Thumbnail Image

Wilson's Disease (WD) Drugs Market 2024-2028

  • Report
  • July 2024
  • 159 Pages
  • Global
From
Krabbe Disease Treatment Market 2024-2028 - Product Thumbnail Image

Krabbe Disease Treatment Market 2024-2028

  • Report
  • June 2024
  • 145 Pages
  • Global
From
Lennox-Gastaut Syndrome Treatment Market 2024-2028 - Product Thumbnail Image

Lennox-Gastaut Syndrome Treatment Market 2024-2028

  • Report
  • January 2024
  • 161 Pages
  • Global
From
Epilepsy Therapeutic Market in APAC 2024-2028 - Product Thumbnail Image

Epilepsy Therapeutic Market in APAC 2024-2028

  • Report
  • January 2024
  • 156 Pages
  • Asia Pacific
From
Loading Indicator

The Central Nervous System Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs that target the central nervous system. These drugs are used to treat a variety of conditions, including neurological disorders, mental health issues, and pain management. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. The Central Nervous System Drugs market is highly competitive, with companies competing to develop the most effective and safe treatments. Companies in the market are constantly researching and developing new drugs, as well as improving existing treatments. Many of these companies are also involved in clinical trials to test the safety and efficacy of their products. Some of the major companies in the Central Nervous System Drugs market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Johnson & Johnson. These companies are involved in the development and production of a wide range of CNS drugs, including antidepressants, antipsychotics, and anticonvulsants. Show Less Read more